Merian Life Sciences ApS: Financial statements 2025
CVR: 40288589
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
Merian Life Sciences ApS (CVR 40288589) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 280,804 and a net result of DKK -36,911 compared with DKK 835,491 the year before. That is a decrease of 73.8% compared with the year before. Equity in the 2025 report amounted to DKK 2,002,914. The solvency ratio was 84.3%.
- Gross Profit
- DKK 280,804
- Profit/Loss
- DKK -36,911
- Equity
- DKK 2,002,914
- Total Assets
- DKK 2,375,732
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | 281K | -37K | 2M | 0 |
| 2024 | - | 1.1M | 835K | 2.2M | 0 |
| 2023 | - | 469K | 330K | 1.5M | 0 |
| 2022 | - | 596K | 433K | 1.2M | 0 |
| 2021 | - | 394K | 290K | 930K | 0 |
Official annual report
How creditworthy is Merian Life Sciences ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
Merian Life Sciences ApS has published its annual report for 2024. Gross profit came to DKK 1,072,060, and the net result was DKK 835,491.
About Merian Life Sciences ApS
Merian Life Sciences ApS is a Danish company of the type Anpartsselskab based in Hellerup, founded in 2019. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Birgitte Menachem and Neil Goldsmith. The company is owned by Birgitte Menachem and Neil Goldsmith. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK 280,804 and a net result of DKK -36,911 compared with DKK 835,491 the year before. Equity in the 2025 report amounted to DKK 2,002,914.